Indo Euro Indchem Q1FY27 revenue up 163% but profit falls 27%
Indo Euro Indchem Ltd reported Q1FY27 standalone results with revenue surging 163% YoY to ₹404.64 lakh. Net profit, however, contracted 27% to ₹10.84 lakh due to rising operational costs. Basic EPS was ₹0.12.
*this image is generated using AI for illustrative purposes only.
Indo Euro Indchem Limited reported a significant expansion in top-line growth for the first quarter of FY27, with revenue from operations rising 163% year-on-year to ₹404.64 lakh. However, this growth did not translate into proportional bottom-line gains, as net profit fell 27% to ₹10.84 lakh compared to ₹14.86 lakh in the same period last year. Basic earnings per share (EPS) for the quarter stood at ₹0.12.
The company’s standalone financial results for the quarter ended June 30, 2026, were approved by the Board of Directors on August 12, 2026. The unaudited results were reviewed by Vora & Associates, Chartered Accountants, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance
Revenue from operations more than doubled compared to the previous year, reflecting increased trading activity in chemicals and other segments. Total income, including other income, stood at ₹414.46 lakh, up from ₹169.09 lakh in Q1FY26. Other income, however, declined 36% to ₹9.82 lakh from ₹15.34 lakh in the prior period.
| Metric | Q1FY27 (₹ Lakh) | Q1FY26 (₹ Lakh) | Change |
|---|---|---|---|
| Revenue from Operations | 404.64 | 153.75 | +163.2% |
| Other Income | 9.82 | 15.34 | -36.0% |
| Total Income | 414.46 | 169.09 | +145.1% |
| Total Expenses | 399.97 | 149.23 | +167.9% |
| Net Profit | 10.84 | 14.86 | -27.1% |
Expenses rose sharply alongside revenue. Purchases of stock-in-trade increased to ₹416.71 lakh from ₹176.64 lakh, while changes in inventories provided a credit of ₹75.27 lakh. Other expenses nearly tripled to ₹52.42 lakh from ₹21.34 lakh, contributing to the compression in profitability despite the revenue surge. Finance costs remained negligible at ₹0.02 lakh, and depreciation was recorded at ₹1.04 lakh.
What the Numbers Show
The divergence between revenue growth and profit decline highlights margin pressure in the current quarter. While revenue grew 163%, total expenses grew at a faster pace of 168%. Specifically, other expenses rose significantly while employee benefits and finance costs remained relatively stable. This suggests that the cost structure is scaling faster than the top-line efficiency, resulting in a lower profit conversion rate compared to the previous year.
Corporate Governance
The Board meeting also focused on internal compliance appointments for the financial year 2026-2027:
- Secretarial Auditor: M/s. VKMG & Associates LLP was re-appointed as Secretarial Auditors.
- Internal Auditor: M/s. Moxit & Associates, Chartered Accountants, was re-appointed as Internal Auditors.
The company operates in a single business segment, trading in chemicals and others, making segment-wise disclosure under Ind AS 108 not applicable. Management noted that no provision for doubtful debts was recommended, citing ongoing efforts for recovery from parties.
Historical Stock Returns for Indo Euro Indchem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +6.12% | -9.81% | -31.85% | -29.00% | +2.50% |
What specific operational strategies will Indo Euro Indchem implement to control the rising 'other expenses' that are currently outpacing revenue growth?
How does management plan to address the margin compression in the chemical trading segment to ensure future profitability scales with top-line expansion?
What is the current status of recovery efforts for outstanding receivables, and could potential bad debt provisions impact future net profit figures?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
